FDA Issues Draft Guidance On Advisory Panel Conflict Disclosures
This article was originally published in The Gray Sheet
Executive Summary
FDA's issued a 1draft guidance Oct. 31 clarifying its process for publicizing FDA advisory panel members' potential conflicts-of-interest